8-19 Adrenergic Agonist / Antagonist Flashcards

1
Q

ALPHA 1 RECEPTOR

Tissues - Actions (3)

A

(1) Most vascular smooth muscle- contracts (inc. vascular resistance)
(2) Pupillary Dilatormuscle- contracts (myDriasis)
(3) Internal Urethral Sphincter- contracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALPHA 2 RECEPTOR Tissues- Actions (3)

A

(1) Adrenergic and cholinergic nerve terminals- inhibits transmitter release (2) Platelets- stimulates aggregation (3) Some vascular smooth muscle- contracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BETA 1 RECEPTOR

Actions (2)

A

(1) Heart- Stimulates rate and force
(2) Juxtaglomerular cells- Stimulates renin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BETA 2 RECEPTOR

Tissues-Actions (4)

A

(1) Relaxes RUV - (Respiratory, Uterine and Vascular) smooth muscle
(2) Liver- stimulates glycogenolysis
(3) Pancreatic B cells- stimulates insulin release
(4) Somatic motor nerve terminals (voluntary muscle)- causes tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BETA 3 RECEPTOR Tissues-Actions

A

(B1 and B2 may also contribute) (1) Fat cells- stimulates lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DOPAMINE 1 RECEPTOR Tissues-Actions

A

(1) Renal and other splanchnic blood vessels- vasoDilates (reduces resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DOPAMINE 2 RECEPTOR Tissues-Actions

A

(1) Nerve terminals- inhibits adenylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Timolol: Half-Life

A

4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Timolol: Mechanism of Action

A

General B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Timolol: Indication

A

Glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nadolol: Half-Life

A

20-24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nadolol: Mechanism of Action

A

General B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nadolol: Indication (2)

A

Long term angina, hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atenolol: Mechanism of Action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Atenolol: Indication (3)

A

Hypertension, angina, MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metoprolol: Mechanism of Action

A

B1-antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Metoprolol: Indication (2)

A

Hypertension, long-term angina rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pindolol: A: Mechanism of Action B: Because of its MOA, it has less _______ effect on the heart.

A

A: B-antagonist with partial agonist activity at both B1 and B2 adrenergic R B: Since some B signal remains (partial agonist), partial agonist have less BRADYCARDIC effect, thus should be used when patients are less tolerant to bradycardic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pindolol: A: Indication B: Therapeutic benefit is good when (indication) is due to _________.

A

A: Hypertension B: Therapeutic benefit is good when HTN is due to HIGH SYMPATHETIC OUTPUT since blockade of endogenous agonist will predominate over partial agonist effect of drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Esmolol: Half-life

A

~9 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Esmolol: Mechanism of Action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Esmolol: A: Indication (3) B: Esmolol has a very ____ half life, so it is given ____(dosage form) in _______ crisis, _____ angina and _______

A

Esmolol: A: Indication: -HTN Crisis -Angina (unstable) -Supraventricular tachycardia B: Esmolol has a very SHORT half life (9 min), so it is given IV in hypertensive crisis, unstable angina, SVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Phenoxy-benzamine: Mechanism of Action

A

General alpha-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Phenoxy-benzamine: Indication

A

Pheochromo-cytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Phentolamine: Mechanism of Action

A

General alpha-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Phentolamine: Indication

A

rx for pheochromocytoma before surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Prazosin: Mechanism of Action

A

[Alpha 1 BLOCKER]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the three cardioselective B1-blockers?

A

Metoprolol, Atenolol, Esmolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the cardiovascular effects of the cardioselective B1-blockers…. -HR/Contractility? -Renin Release? -Vasoregulation?

A

Reduced heart rate and contractility, reduced renin release, reduced vasoconstriction (due to the reduced angio II) [same as non-selective B blockers]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cardioselective B1 BLOCKERS: Therapeutic use (3)

A

Hypertension, angina, arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Cardioselective B1-blockers: Toxicity (4)

A

Depression, insomnia, hypotension, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Cardioselective B1-blockers: Contraindications (2)

A
  • Pt with 2nd/3rd degree heart block -Pt with cardiogenic shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

EPINEPHRINE Half-Life

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

EPINEPHRINE MOA

A

EPINEPHRINE MOA: [General alpha Agonist{HIGH CONCENTRATION} and [General Beta agonist{low concentration}] β€œwith low effort you’ll get a B….with HIGH EFFORT YOU’LL GET AN A”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

EPINEPHRINE ELIMINATION

A

COMT β€”> Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

EPINEPHRINE INDICATION (4)

A

EPINEPHRINE Indication: β€’Anaphylaxis β€’Shock β€’Cardiac Arrest β€’Heart Block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

EPINEPHRINE TOXICITY

A

Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

NorEpi HALF-LIFE

A

short (just like EPi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

NorEpi

MOA (2)

A

[General alpha agonist] + [Beta 1 agonist]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

NorEpi Elimination

A

MOA and COMTβ€”> urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

NorEpi Indication

A

Acute hypOtension due to VASODILATORY shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

DOPAMINE TRADE NAME

A

DOPAMINE ;-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

DOPAMINE HALF-LIFE

A

2-3 MIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

DOPAMINE MOA

A

DOPAMINE MOA: [General Beta Agonist] + [SOME alpha agonist activity]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

DOPAMINE ELIMINATION

A

MOA AND COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

DOPAMINE INDICATION

A

Cardiogenic Shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

IsoProterenol Half-life

A

short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

IsoProterenol

MOA

A

[General Beta Agonist]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

IsoProterenol Elimination

A

COMT β€”> Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

IsoProterenol INDICATIONS (2)

A

IsoProterenol 1) Transient Heart Block 2) Bronchospasm during Anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

DoButamine HALF-LIFE

A

2-3 MIN

52
Q

DoButamine MOA

A

[MOSTLY Beta 1 AGONIST] ; some beta 2 activity

53
Q

DoButamine ELIMINATION

A

COMTβ€”> Urine

54
Q

DoButamine INDICATION

A

Short term for INC cardiac contractility

55
Q

DoButamine TOXICITY

A

Hypotension (from vasoDilation;Beta 2 activity)

56
Q

IsoProterenol TOXICITY

A

Tachyarrhythmias

57
Q

DOPAMINE Toxicity (2)

A

-Low BP -Ischemia

58
Q

Norepi TOXICITY (2)

A
  • Ischemia - NE Extravasation (IV) –> Use [PhenTolamine as antidote]
59
Q

EPININEPHRINE TOXICITY

A

ARRHYTHMIAS

60
Q

NorEPINEPHRINE -CO? -TPR? -HR? -OVERALL MAP?

A

NorEPINEPHRINE Physiological effects: ΒΊIncreased CO; ΒΊincrease TPR; ΒΊdecrease HR (baroreflex); ΒΊoverall increased MAP

61
Q

DOPAMINE LOW DOSE: _____ TPR/ _______ CO; vs. HIGH DOSE: ______ TPR and _____ MAP

A

DOPAMINE LOW DOSE: decreased TPR/ increased CO; vs. HIGH DOSE: Increased MAP and TPR

62
Q

IsoProterenol Physiological effects -TPR? -CO? -MAP? -Broncho____(constricts/dilates)

A

IsoProterenol Physiological effects: Decreased TPR; Increased CO; Small decrease in MAP; bronchodilation

63
Q

DOBUTAMINE Physiological effects -CO? -inotropic vs. chronotropic?

A

DOBUTAMINE Physiological effects: Increased CO -MORE INOTROPIC due to [LOW INVOLVEMENT OF baroreceptor reflex which would normally INC chronotropic effects from compensation to hypOtension]`

64
Q

TERBUTALINE Physiological effects -Broncho____(constricts/dilates) -Uterine contraction vs. relaxation?

A

TERBUTALINE Physiological effects: Bronchodilation; Uterine relaxation

65
Q

TERBUTALINE Toxicity (3)

A

TERBUTALINE Toxicity: Tachycardia; Muscle tremor; Tolerance

66
Q

TERBUTALINE MOA

A

TERBUTALINE [BETA TWO AGONIST]

67
Q

TERBUTALINE INDICATIONS

A

TERBUTALINE Prevent and Reverse Bronchospasm in [Asthma/Bronchitis/Emphysema] Pts

68
Q

ALBUTEROL MOA

A

[BETA TWO AGONIST]

69
Q

ALBUTEROL INDICATION

A

Bronchial Smooth Muscle Relaxation

70
Q

PHENYLEPHRINE Physiological effects: -TPR? -MAP? -HR? -PUPIL? -BRONCHIOLE SECRETION?

A

PHENYLEPHRINE Physiological effects: Increased TPR and MAP; decreased HR (baroreflex); Pupillary dilation; decrease bronchiole and sinus secretions.

71
Q

PHENYLEPHRINE HALF-LIFE

A

[less than 1 hour] - metabolizes slowly because it is NOT degraded by [Plasma COMT]

72
Q

PHENYLEPHRINE Mechanism of Action

A

[alpha 1 AGONIST]

73
Q

PHENYLEPHRINE ELIMINATION

A

MAO

74
Q

PHENYLEPHRINE Indication (4)

A

-PRESSOR during Anesthesia -Nasal Congestion -Dilate Pupils for Eye Exam (mydriatic agent) -SVT

75
Q

PHENYLEPHRINE Toxicity

A

HTN

76
Q

PHENYLEPHRINE: Can Cause ____[INC/DEC] in HR due to _____ ______

A

PHENYLEPHRINE: Can cause DEC in HR due to [Baroreceptor Reflex] when peripheral vasoconstriction is initiated

77
Q

CLONIDINE MOA

A

[alpha TWO AGONIST]

78
Q

CLONIDINE ELIMINATION

A

Urinated Out

79
Q

CLONIDINE INDICATION (2)

A

β€’HTN β€’Analgesia

80
Q

CLONIDINE TOXICITY

A

CLONIDINE Toxicity: (x) Dry Mouth (x) HTN Crisis if withdrawn after Chronic Usage

81
Q

CLONIDINE Works by _____[INC/DEC] Peripheral vasoconstriction CENTRALLY but will have some _____[INC/DEC] Peripheral vasoconstriction by acting directly in the ______

A

CLONIDINE Works by DECREASING Peripheral vasoconstriction CENTRALLY (inhibits sympathetics) but will have SOME INC peripheral vasoconstriction by acting directly in the PERIPHERY/ BODY

82
Q

AMPHETAMINE Physiological effects: -TPR? -Inotropic vs. Chronotropic? -MAP?

A

AMPHETAMINE Physiological effects: ΒΊIncreased TPR/diastolic BP ΒΊPositive inotropic and Positive chronotropic effects; ΒΊ increased MAP pressure

83
Q

AMPHETAMINE MOA

A

AMPHETAMINE MOA: [Indirect sympathoMimetic] - Causes NorEpi Release

84
Q

AMPHETAMINE INDICATION (3)

A

ADHD / narcolepsy / [nasal congestion]

85
Q

AMPHETAMINE Toxicity (4)

A

AMPHETAMINE Toxicity: (x) Tachycardia (x) HTN (x) Anxiety (x) tyramine accumulation if patient has taken MAO inhibitor within the previous 2 weeks is why MAO inhibitors are CONTRAINDICATED w/Amphetamine β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”- β€œT.H.A.t Amphetamine is TOXIC”

86
Q

AMPHETAMINE is an _______ Agent

A

AMPHETAMINE is an Anorexic Agent

87
Q

PARTIAL BETA AGONIST Examples (1)

A

-Pindolol

88
Q

PARTIAL BETA AGONIST Mechanism: Treats HTN effectively when HTN is secondary to________. [Partial Beta Agonist] work by reducing _______ binding. They will still INC HR/Contractility BUT NOT AS MUCH AS _______ and since it prevents _______, the baseline HR/Contractility actually goes down from where it was initially **Is used for pts who can’t tolerate _______ very well with traditional [_______ _______ blockers]

A

PARTIAL BETA RECEPTOR AGONIST Mechanism: Treats HTN effectively when HTN is secondary to [HIGH Sympathetics]. [Partial Beta Agonist] work by reducing [NOrEPI/EPI] binding. Pindolol will still INC HR/Contractility BUT NOT AS MUCH AS NOrEPI/EPI and since it prevents NOREPI/EPI, the baseline HR/Contractility actually goes down from where it was initially **Is used for pts who can’t tolerate bradycardia very well with traditional [Cardioselective beta blockers]

89
Q

PARTIAL BETA AGONIST -HR? -Heart Contractility? -Renin Release?

A

PARTIAL BETA RECEPTOR AGONIST CV Effects (These CV Effects are most manifested when Sympathetics is the original cause) *DEC HR *DEC Heart Contractility *DEC Renin Release

90
Q

PARTIAL BETA RECEPTOR AGONIST USES (1)

A

HTN (for pt less tolerant to bradycardia/reduced exercise capacity)

91
Q

PARTIAL BETA RECEPTOR AGONIST TOXICITY (5)

A

Toxicity are the same as the [NON-SELECTIVE BETA BLOCKERS] (1) Bronchospasm (2) mask symptoms of hypoglycemia (3) CNS effects including insomnia and depression (4) can raise triglycerides (5) bradycardia

92
Q

PARTIAL BETA RECEPTOR AGONIST Contraindications (2)

A

*2nd/3rd Degree heart Block *Cardiogenic Shock

93
Q

ALPHA ADRENERGIC RECEPTOR BLOCKER EXAMPLES (2)

A

ALPHA ADRENERGIC RECEPTOR BLOCKER *[iRReversible Phenoxybenazmine] *[REVERSIBLE PHENTOLAMINE]

94
Q

ALPHA ADRENERGIC RECEPTOR BLOCKER CV Effects (3)

A

ALPHA ADRENERGIC RECEPTOR BLOCKER 1. Prevents vasoconstriction–> DEC BPβ€”>but will cause reflex INC in NorEpi release 2. INC inotropy and INC Chronotropy due to blocking the [a2 pre-synaptic receptor] –> Release of NorEpi @ nerve terminals 3. will unmasks vasodilatory effect of Epi

95
Q

ALPHA ADRENERGIC RECEPTOR BLOCKER USES (2)

A

*perioperative tx of pheochromocytoma *Dermal Necrosis

96
Q

GENERAL ALPHA BLOCKER TOXICITY (3)

A

GENERAL ALPHA BLOCKER Toxicity: (x) Prolonged hypOtension (x) Reflex Tachycardia (x) Nasal Congestion β€œIt’s TOXIC to give ur pt [General Alpha Blocker’s] PRN”

97
Q

ALPHA ADRENERGIC RECEPTOR BLOCKER Contraindications (1)

A

ALPHA ADRENERGIC RECEPTOR BLOCKER Contraindications: Pt with Coronary Artery Dz

98
Q

ALPHA 1 RECEPTOR BLOCKER EXAMPLES (3)

A

ALPHA 1 RECEPTOR BLOCKER Examples: -Prazosin -Doxazosin - Terazosin

99
Q

ALPHA 1 RECEPTOR BLOCKER CV Effects (2) *Prevents _______ *[Less HR INC / Contractility INC] than [NON-selctive alpha receptor blockers] because ____________. This ultimately DEC _______ release in the synaptic cleft and SA Node is not stimulated any further

A

ALPHA 1 RECEPTOR BLOCKER CV Effects: *Prevents Vasoconstriction *[Less HR INC / Contractility INC] than [NON-selctive alpha receptor blockers] since [alpha 2 receptor] on [pre-synpatic nerve terminal] IS STILL FUNCTIONAL and can still negatively feedback when NorEpi is releasedβ€”> ultimately DEC NorEpi release in the synaptic cleft and SA Node is not stimulated no further

100
Q

ALPHA 1 RECEPTOR BLOCKER USES (2)

A

ALPHA 1 RECEPTOR BLOCKER ΒΊHTN ΒΊBenign Prostatic Hyperplasia

101
Q

ALPHA 1 RECEPTOR BLOCKER TOXICITY (2)

A

ALPHA 1 RECEPTOR BLOCKER TOXICITY: (x) Syncope (x) Orthostatic hypOtension

102
Q

Methylphenidate: MOA

A

Indirect sympathomimetic (increases NE and dopamine)

103
Q

Methylphenidate: Indication

A

ADHD

104
Q

Ephedrine: MOA

A

Indirect sympathomimetic

105
Q

Ephedrine: Indication

A

Pressor agent with anesthesia

106
Q

What main drugs make up the Amphetamine family ? (6)

A
  1. Amphetamine 2. Methamphetamine 3. Methylphenidate 4. Ephedrine 5. Pseudoephedrine 6. Tyramine
107
Q

Pseudo-ephedrine: MOA

A

Indirect sympathomimetic

108
Q

Pseudo-ephedrine: Indication

A

Nasal decongestion

109
Q

Tyramine: MOA

A

Displaces NE

110
Q

Tyramine: Half-life

A

Normally very short

111
Q

Tyramine: Indications

A

Not therapeutic

112
Q

Tyramine: Elimination

A

MAO

113
Q

Propanolol: MOA

A

General (non-selective) Beta Blocker

114
Q

Propanolol: Indications (3)

A
  1. Hypertension 2. Angina due to atherosclerosis 3. MI
115
Q

Timolol: MOA

A

General (non-selective) Beta Blocker

116
Q

Timolol: Indications

A

Glaucoma

117
Q

Nadolol: Half-life

A

20-24 hrs

118
Q

Nadolol: MOA

A

General (non-selective) Beta-blocker

119
Q

Nadolol: Indications (2)

A
  1. Long-term angina 2. Hypertension
120
Q

What are the Non-selective Beta-blockers? (3)

A

Propanolol, nadolol, timolol

121
Q

Cardiovascular effects of Non-selective Beta-blockers? (3)

A
  1. Reduced heart rate 2. Reduced contractility 3. Reduced vasoconstriction (as a result of reduced RENIN release)
122
Q

Effect of Non-selective Beta-blockers on bronchioles? (1)

A

Can cause bronchiole constriction in those with asthma or COPD.

123
Q

Non-selective Beta-blockers: Toxicity (5)

A
  1. Bronchospasm 2. Bradycardia 3. CNS effects (insomnia/depression) 4. MASK sx of hypOglycemia 5. Triglyceride INC β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”- β€œ(General) B Blockers Can Modulate Triglycerides β€œ
124
Q

Non-selective Beta-blockers: Contraindications (4)

A
  1. Heart Block 2. Sinus bradycardia 3. Bronchial Asthma 4. Cardiogenic shock β€œ[He Should Be Careful] w/General Beta Blockers”
125
Q

LIST THE 5 Drugs Eliminated by COMT

A

β€œCOMT d.i.N.e.D on 5 Drugs” 1. doButamine 2. isoProterenol 3. NOREPI [MAO and COMT] 4 epi 5. DOPAMINE [MAO and COMT]